SI-BONE Past Earnings Performance
Past criteria checks 0/6
SI-BONE's earnings have been declining at an average annual rate of -5.6%, while the Medical Equipment industry saw earnings growing at 11.4% annually. Revenues have been growing at an average rate of 18.7% per year.
Key information
-5.6%
Earnings growth rate
4.7%
EPS growth rate
Medical Equipment Industry Growth | 8.9% |
Revenue growth rate | 18.7% |
Return on equity | -24.8% |
Net Margin | -27.1% |
Last Earnings Update | 30 Jun 2024 |
Recent past performance updates
Recent updates
Is SI-BONE (NASDAQ:SIBN) Using Too Much Debt?
Sep 25SI-BONE, Inc.'s (NASDAQ:SIBN) P/S Is On The Mark
Apr 01Analyst Estimates: Here's What Brokers Think Of SI-BONE, Inc. (NASDAQ:SIBN) After Its Full-Year Report
Feb 29Is SI-BONE (NASDAQ:SIBN) Using Debt In A Risky Way?
Feb 28Is SI-BONE (NASDAQ:SIBN) Using Too Much Debt?
Nov 12Is SI-BONE (NASDAQ:SIBN) Using Too Much Debt?
Aug 09Is SI-BONE (NASDAQ:SIBN) A Risky Investment?
Apr 20Is SI-BONE (NASDAQ:SIBN) Using Debt In A Risky Way?
Jan 01Is SI-BONE (NASDAQ:SIBN) Using Debt In A Risky Way?
Sep 24SI-BONE (NASDAQ:SIBN) Has Debt But No Earnings; Should You Worry?
Apr 19Is SI-BONE (NASDAQ:SIBN) Using Debt In A Risky Way?
Jan 05Is SI-BONE (NASDAQ:SIBN) Using Debt In A Risky Way?
Oct 05Does SI-BONE (NASDAQ:SIBN) Have A Healthy Balance Sheet?
Jul 05Revenue & Expenses Breakdown
How SI-BONE makes and spends money. Based on latest reported earnings, on an LTM basis.
Earnings and Revenue History
Date | Revenue | Earnings | G+A Expenses | R&D Expenses |
---|---|---|---|---|
30 Jun 24 | 151 | -41 | 146 | 17 |
31 Mar 24 | 144 | -43 | 144 | 16 |
31 Dec 23 | 139 | -43 | 141 | 15 |
30 Sep 23 | 132 | -44 | 139 | 14 |
30 Jun 23 | 124 | -48 | 137 | 14 |
31 Mar 23 | 117 | -55 | 139 | 13 |
31 Dec 22 | 106 | -61 | 137 | 14 |
30 Sep 22 | 100 | -65 | 135 | 13 |
30 Jun 22 | 96 | -66 | 132 | 13 |
31 Mar 22 | 92 | -62 | 125 | 13 |
31 Dec 21 | 90 | -57 | 119 | 12 |
30 Sep 21 | 87 | -51 | 112 | 12 |
30 Jun 21 | 85 | -45 | 105 | 11 |
31 Mar 21 | 77 | -43 | 96 | 10 |
31 Dec 20 | 73 | -44 | 94 | 9 |
30 Sep 20 | 71 | -44 | 92 | 9 |
30 Jun 20 | 67 | -46 | 90 | 8 |
31 Mar 20 | 69 | -42 | 90 | 8 |
31 Dec 19 | 67 | -38 | 86 | 7 |
30 Sep 19 | 63 | -35 | 79 | 7 |
30 Jun 19 | 60 | -28 | 72 | 7 |
31 Mar 19 | 58 | -23 | 64 | 6 |
31 Dec 18 | 55 | -17 | 57 | 5 |
30 Sep 18 | 54 | -17 | 54 | 4 |
30 Jun 18 | 52 | -18 | 55 | 4 |
31 Mar 18 | 49 | -21 | 55 | 4 |
31 Dec 17 | 48 | -23 | 56 | 5 |
31 Mar 17 | 44 | -21 | 49 | 6 |
31 Dec 16 | 42 | -21 | 49 | 5 |
31 Mar 16 | 40 | -27 | 54 | 8 |
31 Dec 15 | 41 | -28 | 54 | 9 |
30 Sep 15 | 42 | -32 | 56 | 8 |
31 Mar 15 | 40 | -32 | 53 | 9 |
31 Dec 14 | 40 | -28 | 51 | 9 |
31 Dec 13 | 49 | -6 | 42 | 8 |
Quality Earnings: SIBN is currently unprofitable.
Growing Profit Margin: SIBN is currently unprofitable.
Free Cash Flow vs Earnings Analysis
Past Earnings Growth Analysis
Earnings Trend: SIBN is unprofitable, and losses have increased over the past 5 years at a rate of 5.6% per year.
Accelerating Growth: Unable to compare SIBN's earnings growth over the past year to its 5-year average as it is currently unprofitable
Earnings vs Industry: SIBN is unprofitable, making it difficult to compare its past year earnings growth to the Medical Equipment industry (7.2%).
Return on Equity
High ROE: SIBN has a negative Return on Equity (-24.8%), as it is currently unprofitable.